Skip to content

Genetic Polymorphisms Associated With Vertebral Osteochondrosis

Evaluation of Polymorphisms in the Vitamin D Receptor and Involved in Inflammation Associated With Vertebral Osteochondrosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04195529
Acronym
OSTEOGEN
Enrollment
100
Registered
2019-12-12
Start date
2019-11-19
Completion date
2022-12-31
Last updated
2019-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Osteochondrosis

Brief summary

The present study is proposed for the identification of phenotype, biochemical and genetic markers in adult symptomatic spinal osteochondrosis to promote the early diagnosis of this pathological condition and to establish possible therapeutic targets that favor a conservative approach aimed at treating patients.

Detailed description

The primary outcome is to determine the association between specific phenotypic characteristics of osteochondrosis, in particular linked to osteo-cartilaginous degeneration, with the identified vitamin D receptor genotypes. The secondary outcomes are to evaluate the circulating levels of the osteo-cartilage degradation markers, of the vitamin D and to evaluate the association of the osteochondrosis phenotype with variants in genes involved in inflammatory processes.

Interventions

GENETICpresence of genetic variants

identification of the presence of genetic variants

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* males and females * 18≤age ≤ 65 years old * patients with adult spinal osteochondrosis

Exclusion criteria

* age \< 18 or \> 65 years old * chronic major diseases such as diabetes, autoimmune diseases, cardiovascular diseases, malignancies

Design outcomes

Primary

MeasureTime frameDescription
association of spinal osteochondrosis with specific VDR genotypes1st yearDetermine the association between specific phenotypic characteristics of osteochondrosis identified by means of MRI, in particular the presence of wavy/Irregular, notched endplates or Shmorl's nodes with FokI, BsmI, ApaI, TaqI VDR genotypes, assessed by means of TaqMan SNP Genotyping Assays

Secondary

MeasureTime frameDescription
association of spinal osteochondrosis with specific biochemical markers2nd yearDetermine the association between specific phenotypic characteristics of osteochondrosis identified by means of MRI, in particular the presence of wavy/Irregular, notched endplates or Shmorl's nodes with the circulating levels of the osteo-cartilage degradation markers CTx-I, CTx-II and of the vitamin D.

Other

MeasureTime frameDescription
association of spinal osteochondrosis with specific inflammatory genotypes1st yearExploratory evaluation of the association of the osteochondrosis phenotype with variants in genes involved in inflammatory processes, such as IL-1B and IL-1RN.

Countries

Italy

Contacts

Primary ContactAlessandra Colombini
alessandra.colombini@grupposandonato.it0266214067
Backup ContactElena Cittera
elena.cittera@grupposandonato.it0266214057

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026